scholarly article | Q13442814 |
P819 | ADS bibcode | 1991PNAS...88.4153S |
P356 | DOI | 10.1073/PNAS.88.10.4153 |
P953 | full work available at URL | https://europepmc.org/articles/PMC51616 |
https://europepmc.org/articles/PMC51616?pdf=render | ||
https://pnas.org/doi/pdf/10.1073/pnas.88.10.4153 | ||
P932 | PMC publication ID | 51616 |
P698 | PubMed publication ID | 1851995 |
P5875 | ResearchGate publication ID | 21303979 |
P50 | author | Andrew Schally | Q141147 |
P2093 | author name string | A. V. Schally | |
K. Lapis | |||
J. D. Neill | |||
B. Szende | |||
J. Timar | |||
J. J. Mulchahey | |||
G. Srkalovic | |||
A. Csikos | |||
K. Szepeshazi | |||
P2860 | cites work | A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid | Q26778512 |
Subcellular localization of the receptor for gonadotropin-releasing hormone in pituitary and ovarian tissue | Q28565420 | ||
Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone | Q33841289 | ||
Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone | Q34598135 | ||
Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. | Q36245969 | ||
Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists | Q46687762 | ||
Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists* | Q58854013 | ||
Luteinizing hormone-releasing hormone (LH-RH) binding to purified rat pituitary nuclei | Q58854059 | ||
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist | Q59065919 | ||
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells | Q63359359 | ||
Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression | Q68089195 | ||
Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75 | Q68451778 | ||
Cultured mammary carcinoma cells contain gonadotropin-releasing hormone-like immunoreactivity, GnRH binding sites and chorionic gonadotropin | Q68943980 | ||
Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia | Q69076825 | ||
Carcinoma of the exocrine pancreas: a sex hormone responsive tumour? | Q69118398 | ||
Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer | Q69370646 | ||
Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer | Q69372214 | ||
Membrane receptors for peptides in experimental and human pancreatic cancers | Q69375881 | ||
Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma | Q69377509 | ||
Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin | Q69377991 | ||
Gonadotropin-releasing hormone binding sites in human breast carcinoma | Q70094439 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4153-4156 | |
P577 | publication date | 1991-05-01 | |
1991-05-15 | |||
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells | |
P478 | volume | 88 |
Q102995406 | A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer |
Q48002807 | A somatostatin analogue induces translocation of Ku 86 autoantigen from the cytosol to the nucleus in colon tumour cells |
Q77994303 | A specifically radiolabeled somatostatin analog with strong antitumor activity induces apoptosis and accumulates in the cytosol and the nucleus of HT29 human colon carcinoma cells |
Q40970844 | A study on liposomal encapsulation of a lipophilic prodrug of LHRH. |
Q33894753 | Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix |
Q35975764 | Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone |
Q38980206 | LHRH-Targeted Drug Delivery Systems for Cancer Therapy. |
Q61838848 | Localization of luteinizing-hormone releasing hormone binding sites in the gastric mucosa of suckling rats |
Q57555436 | Localization of the three GnRH types and GnRH receptors in the brain of a cichlid fish: Insights into their neuroendocrine and neuromodulator functions |
Q37724516 | Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors |
Q40915919 | Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature |
Q44499115 | Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer |
Q41041858 | Signal transduction of the gonadotropin releasing hormone (GnRH) receptor: cross-talk of calcium, protein kinase C (PKC), and arachidonic acid |
Q57105900 | Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer |
Search more.